Cynosure, Inc. (CYNO) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $25.87 to $27.53 in the past one-month time frame.
In the last 30 days, while this company did not witness any estimate revisions, the Zacks Consensus Estimate has moved higher suggesting that more solid trading could be ahead for Cynosure. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Cynosure currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is negative.
Some better-ranked stocks in the healthcare industry include Actelion Ltd. (ALIOF), Gentium S.p.A (GENT) and Cambrex Corporation. (CBM). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment